Report Highlights
This report provides an overview of the global market on anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report details the anti-obesity drugs market based on drug type, distribution channel, and region.
Report Includes
- An overview of the current and future global markets for anti-obesity drugs
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the global anti-obesity drugs market, and corresponding market share analysis based on drug type, distribution channel, and region
- Overview of ESG outlook with emphasis on sustainability trends and factors on anti-obesity drugs market
- Identification of the major vendors in the global market for anti-obesity drugs, along with an analysis of the structure of this industry, including company market shares, M&A deals and venture fundings
- Profiles of the leading global players
Report Scope
The report’s scope includes an overview of the global market for anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading market players’ profiles, marketed products, pipeline products, and recent market activities are provided. The report details market for anti-obesity drugs based on drug type, distribution channel, and region. Based on drug type, the market is segmented into prescription drugs, and over-the-counter (OTC) drugs. The market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies on the basis of distribution channel. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||
| Forecast period considered | 2023-2028 | ||||||||||
| Base year market size | 2023-2028 | ||||||||||
| Market size forecast | $11.3 billion | ||||||||||
| Growth rate | CAGR of 28.9% for the forecast period of 2023-2028 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | Drug Type, Distribution Channel, and Region | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||
| Countries covered | U.S., Mexico, Canada, France, Germany, U.K., Italy, Spain, China, India, Japan, Middle East, Africa, and South America | ||||||||||
| Key Market Drivers |
|
||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Rising prevalence of obesity and associated health problems.
- Increasing awareness regarding health-risks associated with obesity.
- Growing pharmaceutical research and development spending on developing anti-obesity drugs.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Weight Management Products, Fitness Equipment, and Services Market
The global market for weight management products, fitness equipment, and services is estimated to increase from $278.5 billion in 2023 to reach $424.8 billion by 2028, at a compound annual growth rate (CAGR) of 8.8% from 2023 through 2028.
Weight Loss and Weight Management Diet Market
This report provides a comparative study of different types of diets with emphasis on weight management. It offers an understanding of the role of genes, guts, and dietary nutrition in weight management.
Bariatric Surgery: Global Markets for Services and Devices
The global market for bariatric devices should increase from $1.5 billion in 2020 to nearly $2.2 billion by 2025 at a compound annual growth rate (CAGR) of 7.5% during the forecast period, 2020-2025.
Recent Reports
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.
Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Rare Disease Diagnostics: Technologies and Global Markets
The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.
Breakthrough Therapies: Market Dynamics and Investment Opportunities
The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.
Softgel Capsules: Global Markets
The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More